Alumis ALMS
NASDAQ ALMS
$9.90 +0.10 (+1.02%)
At close: Sep 10, 2026 · 4:00 PM EDT

Alumis (ALMS) Other Non Operating Income (2023 - 2026)

Alumis' (ALMS) quarterly Other Non Operating Income came in at -$71000.0 in Q2 2026, down 100.04% year-over-year from $187.9 million in Q2 2025, and down 31.48% quarter-over-quarter from -$54000.0 in Q3 2025.

Analysis

Alumis (ALMS) Other Non Operating Income (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Other Non Operating Income for 4 consecutive years, with -$71000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non Operating Income fell 100.04% year-over-year to -$71000.0 in Q2 2026; TTM through Jun 2026 was $187.8 million, a 7.38% decrease from a year earlier, with the FY2025 full-year figure at $187.9 million, up 1873.81% from the prior year.
  • Other Non Operating Income was -$71000.0 for Q2 2026 at Alumis, down from -$54000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $187.9 million in Q2 2025 and troughed at -$3.1 million in Q1 2024.
  • A 4-year average of $19.7 million and a median of -$49000.0 in 2025 frame the typical range for Other Non Operating Income.
  • Across the five-year window, Other Non Operating Income sank 634.95% in 2024 and soared 8230.98% in 2025, its largest moves.
  • Over 4 years, Other Non Operating Income stood at -$551000.0 in 2023, then surged by 2808.89% to $14.9 million in 2024, then slumped by 100.36% to -$54000.0 in 2025, then slumped by 31.48% to -$71000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$71000.0 (Q2 2026), -$54000.0 (Q3 2025), and $187.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Alumis 1.27 Bn 765.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71,000.00
Sep 30, 2025 -54,000.00
Jun 30, 2025 187.91 Mn
Mar 31, 2025 -44,000.00
Dec 31, 2024 14.93 Mn
Sep 30, 2024 -40,000.00
Jun 30, 2024 -2.31 Mn
Mar 31, 2024 -3.10 Mn
Sep 30, 2023 -551,000.00
Jun 30, 2023 432,000.00